ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
77,80
3,00
(4,01%)
Geschlossen 22 Januar 10:00PM
Echtzeitdaten

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
77,80
Gebot
77,60
Fragen
78,00
Volumen
19.043
74,60 Tagesbereich 78,00
72,40 52-Wochen-Bereich 140,00
Marktkapitalisierung
Handelsende
74,80
Handelsbeginn
74,60
Letzte Trade
5
@
78
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
12.031
Ausgegebene Aktien
4.462.229.293
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
4,28
Gewinn pro Aktie (EPS)
18,75
Erlöse
232,26B
Nettogewinn
83,68B

Über Novo Nordisk

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Bagsvaerd, Dnk
Gegründet
-
Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOVA. The last closing price for Novo Nordisk was 74,80 €. Over the last year, Novo Nordisk shares have traded in a share price range of 72,40 € to 140,00 €.

Novo Nordisk currently has 4.462.229.293 shares in issue. The market capitalisation of Novo Nordisk is 333,77 € billion. Novo Nordisk has a price to earnings ratio (PE ratio) of 4.28.

NOVA Neueste Nachrichten

Success of the Simplified Cash Tender Offer for the Shares & bons de souscription d’actions of Novagali Pharma SA by Santen...

Regulatory News: Santen Pharmaceutical Co., Ltd. (“Santen”) and Novagali Pharma SA (“Novagali”) announced today the success of the simplified cash tender offer for the...

Novagali Pharma: Revenue for the 3rd quarter of 2011

Regulatory News: Novagali Pharma (Paris:NOVA), a pharmaceutical company that develops and markets innovative ophthalmic products, today announces its revenue for the first...

Santen Pharmaceutical Co., Ltd. Completes the Acquisition of a Controlling Interest in Novagali Pharma S.A.

Regulatory News: Following the press release of September 28, 2011, in accordance with articles 223-2 and 223-6 of the general regulations of the French Autorité des...

Signing of an Acquisition of a Controlling Interest in Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.

Regulatory News: Santen Pharmaceutical Co., Ltd. (Osaka, Ticker Code 4536JP) (hereafter “Santen”), a leading Japanese pharmaceutical company, and Novagali Pharma S.A...

Novagali Pharma Reports Positive Results in Phase II Study for Catioprost® vs. Travatan Z® in Patients with Glaucoma & Ocul...

Regulatory News: Novagali Pharma (Paris:NOVA) announced today US phase II positive results on the efficacy and safety of Catioprost® in patients with glaucoma and...

Novagali: Availability of the 2011 half-year financial report

Regulatory News: Novagali Pharma (Paris:NOVA), a pharmaceutical company that develops and markets innovative ophthalmic products, informs its shareholders and the financial...

Novagali: 2011 First-Half Results

Regulatory News: Novagali Pharma (Paris:NOVA), a pharmaceutical company that develops and markets innovative ophthalmic products, today announces its half-year results1 to...

Novagali : Revenue for the first half of 2011

Regulatory News: Novagali (Paris:NOVA): Novagali Pharma, a pharmaceutical company that develops and sells innovative ophthalmic products, today announces its revenue for...

Novagali Pharma: Supervisory Board Strengthened Significantly

Regulatory News: Approval of all the resolutions proposed at the Combined General Meeting of the shareholders on June 22, 2011 Novagali Pharma (Paris:NOVA), a...

Novagali Pharma and Ardeo Sign an Exclusive Distribution Agreement for Nova23041 in the United States and Canada

Regulatory News: Novagali Pharma (Paris:NOVA), a pharmaceutical company that develops innovative ophthalmic products, can today announce that it has signed an exclusive...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-5.2-6.265060240968383.273.5999991923377.45459559DE
4-8-9.3240093240185.886.473.5999991675381.07851614DE
12-26.2-25.1923076923104108.572.41203189.76619709DE
26-42.7-35.4356846473120.512672.4827798.69298168DE
52-21-21.255060728798.814072.47966108.62339868DE
156-96.7-55.4154727794174.5187.572.47495106.86908883DE
26022.340.180180180255.5187.544.64404103.71231772DE

NOVA - Frequently Asked Questions (FAQ)

What is the current Novo Nordisk share price?
The current share price of Novo Nordisk is 77,80 €
How many Novo Nordisk shares are in issue?
Novo Nordisk has 4.462.229.293 shares in issue
What is the market cap of Novo Nordisk?
The market capitalisation of Novo Nordisk is EUR 333,77B
What is the 1 year trading range for Novo Nordisk share price?
Novo Nordisk has traded in the range of 72,40 € to 140,00 € during the past year
What is the PE ratio of Novo Nordisk?
The price to earnings ratio of Novo Nordisk is 4,28
What is the cash to sales ratio of Novo Nordisk?
The cash to sales ratio of Novo Nordisk is 1,54
What is the reporting currency for Novo Nordisk?
Novo Nordisk reports financial results in DKK
What is the latest annual turnover for Novo Nordisk?
The latest annual turnover of Novo Nordisk is DKK 232,26B
What is the latest annual profit for Novo Nordisk?
The latest annual profit of Novo Nordisk is DKK 83,68B
What is the registered address of Novo Nordisk?
The registered address for Novo Nordisk is NOVO ALLE, BAGSVAERD, DK-2880
What is the Novo Nordisk website address?
The website address for Novo Nordisk is www.novonordisk.com
Which industry sector does Novo Nordisk operate in?
Novo Nordisk operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
UE22US Energy Corp
3,70 €
(65,18%)
37,41k
432Arbor Metals Corp
0,55 €
(60,35%)
3,24M
3PJ1Golden Dory Resourses
0,044 €
(46,67%)
108k
7FJQuebec Innovative Materials Corp
0,095 €
(45,04%)
107,55k
DZJCountry Garden Holdings Co Ltd
0,0698 €
(41,87%)
101,25k
E3O1Nexoptic Technology Corp
0,0075 €
(-51,61%)
9,58k
K1SNKlondike Silver Corporation
0,006 €
(-47,83%)
11k
L7C2Windfall Geotek Inc
0,005 €
(-41,18%)
10,14k
1UR1Bee Vectoring Technologies International Inc
0,0035 €
(-36,36%)
60k
PA8Paion AG
0,0152 €
(-34,48%)
14,41k
PF8European Lithium Limited
0,044 €
(-8,71%)
9,81M
D7GNel ASA
0,1948 €
(-2,11%)
5,12M
432Arbor Metals Corp
0,55 €
(60,35%)
3,24M
1NWNeptune Digital Assets Corp
1,06 €
(17,52%)
1,64M
RQ0DWave Quantum Inc
6,022 €
(9,77%)
1,44M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock